The human genome is estimated to contain one single nucleotide polymorphism (SNP) every 300 base pairs. The presence of LD between SNP markers can be used to save genotyping cost via appropriate SNP tagging strategies, whereas absence or low level of LD between markers generally increase genotyping cost. It is quite common that a large proportion of tagging SNPs in a tagging scheme often turn out to be singleton SNPs, that is, SNPs that only tag themselves rather than contribute power to the rest of a region. If genotyping cost is a major concern, which often is the case at the present time for genome-wide association studies, these singleton tagging SNPs would be the primary targets to be removed from genotyping. It is important, however, to understand the characteristics of such SNPs and estimate the impact of removing them in a study. Using the HapMap genotype data and genome wide expression data, we assessed the distribution and functional implications of singleton SNPs in the human genome. Our results demonstrated that SNPs of potentially higher functional importance (eg, nonsynonymous SNPs, SNPs in splicing sites and SNPs in 5 0 and 3 0 UTR) are associated with a higher tendency to be singleton SNPs than SNPs in intronic and intergenic regions. We further assessed whether singleton SNPs can be tagged using haplotypes of tagSNPs in the three genome wide chips, that is, GeneChip 500k of Affymetrix, HumanHap300 and HumanHap550 of Illumina, and discussed the general implications on genetic association studies.
Introduction
Large scale genome-wide association studies using single nucleotide polymorphisms (SNPs) are now becoming the state of the art in disease genetic studies. 1 -7 For these studies, it is still unfeasible to obtain genotype information for every SNP in the human genome by complete resequencing or genotyping despite rapid technological advancement. Often tagging SNP markers are selected based on information on linkage disequilibrium (LD) between SNP markers, 8 -11 and this has been greatly facilitated by the International HapMap Project. 12, 13 The human genome is thought to contain one SNP every 100 -300 bp. It is now known that LD is not only present between SNPs in close physical proximity along the genome, but is also often present between widely spaced markers to form haplotype blocks. 12, 14 The extent of LD determines the number of markers needed to cover a region or the whole genome. Absence or low level of LD between markers, generally increase genotyping cost. This is often a problem for many tagging schemes since a large proportion of tagging SNPs turns out to be singleton tagSNP markers, which do not contribute power to the rest of a region at all. If genotyping cost is the primary concern, which may often be the case at the present time for genome-wide association studies, these singleton tagging SNPs would be the primary targets for further removal from the final list of SNPs to be genotyped.
An agnostic view about functionality of SNPs is to regard all SNPs, whether singletons or not, as equally important. 15 Whether this is true is not yet clear, and knowledge about this will therefore help understand the practical implications of removing singleton SNPs from genotyping.
In this study, we investigate the distribution and functional implications of singleton SNPs in the human genome using the phase II HapMap data. 13 Since marker density is an important factor in determining whether or not an SNP is independent of other SNPs, we also assessed the HapMap ENCODE data where SNPs were obtained not only from public databases but also from resequencing (http://www.hapmap.org). Our results demonstrated that singleton SNPs distribute across various functional groups and more interestingly a higher proportion of SNPs that have potentially higher importance (such as nonsynonymous SNPs, SNPs in splicing sites, etc) are singletons than of SNPs in introns and intergenic regions. Various factors are also examined on their effect on singleton status and functionality of an SNP. Furthermore, the capability of current commercial genome-wide chips, such as Affymetrix 500 k and Illumina 300 k, in capturing information on singleton SNPs are assessed and discussed. Genome-wide expression data and association analysis The Affymetrix genome-wide expression data was reported by Cheung et al, 18 and downloaded from NCBI at accession number of GSE2552, which includes 58 CEPH individuals (57 individuals as reported by Cheung et al, plus GM12056).
Materials and methods

SNPs and their functional categorization
The raw data was processed by MAS5.0 program and log 2 transformed. Within-as well as between-subject variances were then calculated for each gene in the array. A total number of 1516 genes were studied, which had betweensubject variance/within-subject variance 42 and had missing trait values in fewer than 5% of the individuals who were selected for genome-wide association analysis. Only genes that had 'Presence (P)' calls for all the 100 samples/replicates of the 58 individuals were used in the study. For individuals with two replicates, their averages were obtained. Phase II genotypes for the 58 CEPH individuals were obtained from the HapMap website as above. Genotypes were coded as 0, 1, 2 according to how many copies of the minor alleles were present for an individual, and genomewide association analysis was carried out using regression. SNPs that had a P-value o0.05 after bonferroni correction were taken as potential causal variants (gene expression regulators).
Tagging using single markers and multimarker haplotypes The method of single marker tagging was based on the algorithm developed by Carlson et al, 8 whereas multimarker tagging was based on the algorithm developed by de Bakker et al. 9 A 200 kb window size (100 kb on each side of a hidden SNP) was used for the testing.
Results
Singleton SNPs in the human genome and implications for SNP tagging The number of singleton SNPs in the genome obviously depends on a variety of factors, including populations, sample size, the measure of LD, the LD threshold and marker density and ascertainment. In this study, we based our estimates on the phase II HapMap population samples (with CHB and JPT combined), and used pairwise r 2 as the measure. As r 2 threshold increased from 0.5 to 0.8 and further to 1.0, the proportion of SNPs being singletons in the genome increased in all populationsFfrom 0.06, 0.14 to 0.29 in CEU; 0.06, 0.13 to 0.34 in CHB þ JPT and 0.12, 0.29 to 0.49 in YRI. As the marker density increased, the proportion of SNPs being singletons generally decreased as shown in Figure 1a for CEU samples (bars). It should be noted that the ascertainment schemes have a very important impact on the proportion but also on the composition of singleton SNPs in the genome, as demonstrated in Figure 1a where a much higher proportion of singleton SNPs in ENCODE regions (than in phase I and phase II HapMap) are rare SNP variants with minor allele frequency (MAF) o5%. It is known that both phase I and phase II HapMap tended to bias towards common variants whereas the ENCODE regions were accomplished with resequencing efforts. 12, 13 The most important implication of singleton SNPs in the genome may be their genome typing cost in a genome-wide association study. Because singleton SNPs do not have surrogates to represent them, they themselves have to be genotyped or chosen as tagSNPs in a tagging scheme. As shown in Figure 1b , for phase II HapMap samples at a pairwise tagging threshold of r 2 0.80, at least half of the tagSNPs turned out to be singleton tagSNPs in all the HapMap population samples. These singleton tagSNPs do not contribute power at all to the genome and therefore present as a serious cost constraint for a study. 
Distribution and functional implications of singleton SNPs
It is tempting to exclude singleton SNPs during marker selection to save genotyping cost. Among the 8 876 160 SNPs surveyed in this study, 0.51% of them are nonsynonymous SNPs, 0.46% are synonymous SNPs, 0.04% in splicing sites, 0.2% in 5 0 UTR and 0.84% in 3 0 UTR, with the majority located either within introns (49.78%) or intergenic regions (46.83%). Nonsynonymous SNPs, SNPs in splicing sites, 5 0 UTR and 3 0 UTR are presumably more likely to have functional consequences than intronic or intergenic SNPs. Although these groups of SNPs are only a small minority genome wide, a significant higher proportion of them turned out to be singleton SNPs than the intronic and intergenic SNPs (Figure 2a ). SNPs were also classified according to whether they locate within a region showing significant cross-species sequence conservation (4.66%), or not (95.34%). Again, it is interesting to observe that there are always a higher proportion of SNPs in conserved regions being singletons than in non-conserved regions (Figure 2b) .
A higher proportion of nonsynonymous SNPs, SNPs in splicing sites, SNPs in 5 0 UTR and 3 0 UTR are singletons than intronic and intergenic SNPs, and this observation is consistent across different minor allele frequency spectrum (Figure 3a) . A higher proportion of SNPs in conserved regions were also found to be singletons than of SNPs in non-conserved regions ( Figure 3b ). It is expected that singleton SNPs are generally located in regions of higher recombination rate than non-singletons, as indeed observed in the recent paper by the International HapMap Consortium, 13 where untaggable SNPs were found strongly Singleton SNPs in the human genome X Ke et al enriched in recombination hotspots. By separating SNPs into three different groups according to their recombination rates (o1.0, 1 -3, 43 cM/Mb), SNPs distribution was assessed. As shown in Figure 3c , in all situations, the same pattern was observed. SNPs located in promoter regions (150 bp from transcription starting sites) were also examined separately. At r 2 threshold of 0.8, 17% of SNPs located in promoter regions are singletons for CEU, 19% for CHB þ JPT and 34% for YRI. It is well known that African populations generally have lower LD than Caucasians and Asians. So it is not surprising to observe that YRI have a higher proportion of overall singleton SNPs than CEU, CHB þ JPT (Figure 2 ). Among SNPs that are polymorphic in all three populations and singletons in at least one population, a large number is shared among them (Figure 4a) . Unsurprisingly, singleton SNPs shared among populations were found to be associated with the highest recombination rates, whereas those population-specific ones tended to locate in regions with lower recombination rates (Figure 4b ). Consistent with observations made above and in particular with Figure 3c , SNPs of potentially higher functional importance were associated with a higher proportion of being singletons in all situations, that is, whether they were singletons shared by all three populations, shared by only two populations or observed in only one population (Figure 4c ).
Factors affecting functional implications of singleton SNPs
Singleton status was defined by pairwise LD, which is known to be affected by various factors such as recombination, selection and mutation. Effect of these factors, therefore, need to be accounted for in assessing the functional implications of singleton SNPs. For this purpose, we separate SNPs into two distinct groups: nonsynonymous SNPs, synonymous SNPs, SNPs in splicing sites, SNPs in 5 0 utr and 3 0 utr and SNPs being transcribed were included all in one group which was regarded as functionally more important, whereas the other group was composed of intronic SNPs and SNPs in intergenic regions. MAF, recombination rate and Fst value of a SNP were first examined on their predicting capability on singleton status (Table 1 , upper panel). Although MAF had a very strong impact on singleton status with rare SNPs (MAF o0.1), recombination rate and Fst were found to be more consistently associated with singleton status across different MAF spectrum (Table 1 , upper panel).
These three factors were then assessed together with singleton status on their predicting capability on functional status. As shown in Table 1 (lower panel), singleton status of a SNP was the most persistent predictor of functional status. Both its strength of association (with functional status) and level of significance were consistent across different MAF spectrum. When only MAF and singleton status were used as the predictors in the regression model, singleton status was always more significantly associated with functional status than MAF, with the latter only showing significant association with less common SNPs (MAF o0.3) (data not shown). These results demonstrated that overall singleton SNPs in the human genome tended to locate in functionally important regions more often than non-singleton SNPs.
Singleton SNPs as potential causal variants of natural variation of gene expression
We carried out allelic association testing for 2418 genes which had expression data (ie, presence calls) in at least 95% of the individuals in GSE2552 dataset 18 and with between-subject-variance/within-subject variance 42.0. A genome-wide bonferroni correction was applied to the association testing. Although SNPs with Po0.05 after correction were not necessarily all causal variants which regulate the expression of genes under study, they nevertheless represented a pool of the most likely causal variants. This pool of candidates of gene expression regulators distributed across different regions of the genome, including introns and intergenic regions. Among this pool, more than 10% of SNPs turned out to be singleton SNPs, which was about the genome-wide average ( Figure 1 ). For genes with more than 10 significant SNPs, the proportion of these SNPs being singletons was about 6%, and the figure was about 12% for genes with 2 -10 significant SNPs. For genes with only one significant SNP, expectation would be that the majority of the significant SNPs were singletons, but the ratio was about 40%, indicating a very large proportion of the significant SNPs were non-singletons, but their surrogates just failed the corrected P-value threshold.
The power of commercial chips on detecting singleton SNPs in the human genome We have used the genotype data of the ENCODE regions to assess the potential of using haplotypes formed by nonsingleton tags to tag singletons. Almost all the singleton SNPs were detectable (haplotype r 2 40.80) with 2-marker predictors formed between non-singleton tags within a 200 kb window (data not shown). Various other studies also showed that by using haplotypes formed from multimarker predictors, there was always a big gain in the power of tagSNP sets and tagging efficiency. 3, 9 Here we mainly assess the power on singleton SNPs of the current genome-wide chips, that is, 500 k GeneChip Mapping Sets of Affymetrix and the Sentrix HumanHap300 and HumanHap550 BeadChip by Illumina. GeneChip 500 k is a random SNP set, 19 whereas HumanHap300 is a tagSNP set using LD information of the phase I CEPH HapMap. 20, 21 HumanHap550 is currently under development and is using LD information of the phase II HapMap (http://www.illumina.com). These three products contain 504 152, 317 503 and 561 287 SNPs, respectively. in the autosomes are included into the three products, respectively, well reflecting the nature of these products (Figure 5a ). Given that only about 520 000 SNPs are needed to tag all the autosome common SNPs of the phase II CEU HapMap (Figure 1b) , it is somewhat surprising that only 47% of CEU singletons are included in HumanHap550. This is perhaps due to the fact that HumanHap550 is aimed for more diverse markets other than designed solely for Caucasians as in the case of HumanHap300. For singleton SNPs that are not included as tags, we used multimarker predictors of up to 3 tagSNPs (ie, those SNPs present in the products) to increase the performance of the products. 31, 34 and 31% of these SNPs are captured by GeneChip 500 k, HumanHap300 and HumanHap550, respectively, giving the total power over all singleton SNPs at 44, 60 and 78% (Figure 5b ). There was virtually no gain by increasing the number of markers for the multimarker predictors or by increasing the window sizes (data not shown) and this suggest that the remaining recalcitrant singleton SNPs either locate in or close to recombination hotspots and therefore become untaggable as observed by the International HapMap Consortium, 13 or are too distant from their nearest tagSNPs available in the products.
Discussion
Singleton status was defined by LD, and LD is known to be affected by various factors, such as recombination, selection and mutation. It is known that both positive selection for advantageous variants and purifying selection against deleterious variants can increase LD. 22 As functionally more important regions, such as genic regions and conserved regions, are subject to more selection pressure, the level of LD in these regions is expected to be higher than in functionally less important regions. In the context of this study, a lower frequency of singleton SNPs is expected to be observed in the functionally more important regions. The finding of this study was, however, the opposite. Previous studies showed that repeat sequence can inflate LD in a genomic scale, 12, 23 and lack of interspersed repeat elements were indeed found to be the reason behind weaker LD in evolutionarily more conserved regions. 24 This was consistent with singleton SNP distribution observed in this study. Purifying selection is expected to produce rarer SNPs in functionally important regions. The HapMap is also known to be biased towards common SNPs and therefore led no or fewer proxies for rare SNPs. As a result, singleton SNPs were expected to have generally low MAF, or at least any specific association of singleton status with SNP functionality was expected to be seriously confounded by its association with rare SNPs. Our genome-wide survey revealed that, after effect of rare SNPs was accounted for, singleton SNPs in the human genome tend to locate in regions of functionally high importance more often than non-singleton SNPs. More specifically, a higher proportion of nonsynonymous SNPs, SNPs in splicing sites, SNPs in 5 0 and 3 0 UTR and SNPs in promoter regions were identified to be singleton SNPs than of intronic and intergenic SNPs in the genome. It was also observed that recombination rate was a better predictor of singleton status than MAF and that increased proportion of singleton SNPs among the functionally more important groups coincided with increased recombination rate. It is not clear whether there is any difference between singleton and non-singleton SNPs in the intergenic or intronic regions in terms of their functionality. A comprehensive assessment of this difference is obviously difficult. The list of significant SNPs identified in the genome-wide association analysis of gene expression data represented a pool of possible candidates of gene expression regulators. Many of these SNPs located in intergenic and intronic regions, but overall no difference was observed between proportion of singleton SNPs among this pool and that of the genome-wide average. The present study was mainly carried out with the phase II HapMap data. Although the number of SNPs in the 5 Mb ENCODE regions prevented a detailed stratified analysis, similar patterns also emerged. For example, for HapMap-CEU, at r 2 threshold of 0.8 and MAF45%, 14% of nonsynonymous SNPs were found to be singletons, whereas this figure dropped to about 6% for SNPs in intronic and intergenic regions. More importantly, the observations made with the HapMap phase II data is of practical importance as the HapMap continues to serve as one of the most important sources of information for study design. These observations have some important implications for genome-wide association studies, as LD information derived from the phase II HapMap data continues to be used for marker selection in the foreseeable future. More than 320 000 polymorphic SNPs in the phase II CEU and CHB þ JPT HapMaps are singleton SNPs (r 2 threshold at 0.8), more than 70% of which are common SNP variants, whereas for YRI HapMap the figure is about 800 000 with more than 80% being common variants. Based on estimates from the ENCODE regions, if all polymorphic SNPs are genotyped, there would possibly be about 700 000 singleton SNPs in CEU samples, half of which are common SNP variants. For YRI samples, the figure is more than doubled to 1 500 000 SNPs with 65% of them being common variants. For singleton SNPs located in functionally more important regions, such as coding and conserved regions, they can always be explicitly included into a genotyping scheme on top of the set of markers selected based on an agnostic approach. 1, 3 For other singleton SNPs, haplotype information may be used to improve the power to detect them, as shown by the performance of GeneChip 500 k of Affimetrix and HumanHap300 and HumanHap550 of Illumina. There are still, however, a large proportion of singleton SNPs not properly covered by the chips, especially GeneChip 500 k and HumanHap300. Even by increasing the genome coverage of these commercial chips, some of these SNPs will remain untaggable unless included directly, as suggested by the International HapMap Consortium. 13 For singletons that can be tagged by multimarker predictors, association testing may be complicated by issues, such as how to choose a predictor from potentially multiple alternative sets and dependence on the successful genotyping of predictor markers. As genotyping cost continues to drop, therefore, it may become more attractive to genotype singleton SNPs directly. Under such a scheme, for less common singleton SNPs (such non-singleton SNPs can still be tagged by more commoner SNPs), however, it may still be desirable to exclude them in a disease association study, as there is generally less power to detect their effects.
